Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
03:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

WFH 2016 World Congress

 

24-28 July 2016 Orlando
FAQs
   
Discussion forum - WFH 2016 World Congress
    Topic - Novel therapeutic agents

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 95
Visits: 29
Title: FVIIa-CTP, a novel long acting FVIIa, Comprehensive Pharmacokinetics and Pharmacodynamics and Bioavailability evaluation following Subcutaneous (SC) and Intravenous (IV) administration to hemophilic animal models.
Authors: Gili Hart ,
Centre: OPKO Biologics

You must be registered to reply or comment.

FVIIA-CTP, A NOVEL LONG ACTING FVIIA, COMPREHENSIVE PHARMACOKINETICS AND PHARMACODYNAMICS AND BIOAVAILABILITY EVALUATION FOLLOWING SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) ADMINISTRATION TO HEMOPHILIC ANIMAL MODELS.

Gili Hart
Thread initiator
Subspeciality
Reg: 6/10/2015 9:11:00 AM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 7/5/2016 9:30:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 98
Visits: 72
Title: Factor VIIa-CTP , a novel FVIIa potentially supporting subcutaneous treatment - comprehensive assessment in Hemophilic animals models in preparation for first in human study.
Authors: Gili Hart ,
Centre: OPKO Biologics


 






PosterSessionOnline
Logo Draft
 
Logo Cert